Pet Financial News
Imbria Reports Positive Topline Results for Investigational New Drug Ninerafaxstat in Sufferers with Cardiac Ischemia and Power Stable Angina
– The IMPROVE-ISCHEMIA Phase 2 medical trial met the first endpoint of tolerability and security; 8-weeks therapy with ninerafaxstat additionally demonstrated a statistically important enchancment...
Pet Financial News
Acumen Pharmaceuticals Presents Positive Topline Results from First-in-Human Phase 1 Study of ACU193 for Early Alzheimer’s Disease at the Alzheimer’s Association International Conference (AAIC)...
*One client from Cohort 5 (10 mg/kg Q4W) left out since just received one administration of drug (research study drug terminated after lacunar...
Pet Financial News
ADDF Statement on Topline Results from Phase 3 Trial of Amyloid-Clearing Drug Donanemab
Amyloid-targeting drugs comprise one part of the biology of aging method and are the primary step in establishing several drugs to treat Alzheimer's...
- Advertisement -
Pet Financial News
ADDF Declaration on Topline Outcomes of Stage 3 Trials of Amyloid-Clearing Antibody Gantenerumab
While topline medical trial results reported for gantenerumab are frustrating, we remain in a brand-new age of Alzheimer's drug advancement with extraordinary...
Pet Financial News
Telix Reveals Favorable Topline Outcomes of ZIRCON Stage III Kidney Cancer Imaging Research Study
Summary of Research Study Results ZIRCON Stage III research study of Telix's investigational imaging representative TLX250-CDx in clear cell kidney cell cancer...
Pet Financial News
Telix Reveals Favorable Topline Outcomes of ZIRCON Stage III Kidney Cancer Imaging Research Study
Summary of Research Study Results ZIRCON Stage III research study of Telix's investigational imaging representative TLX250-CDx in clear cell kidney cell cancer...
- Advertisement -
-Advertisement-
Must read
-Advertisement-